EUCTR2011-002147-10-AT
Active, not recruiting
Not Applicable
Influenza vaccination in old age: Immunological and biogerontological characterization of responders and non-responders - Influenza vaccination in old age
Institute for Biomedical Aging Research0 sitesAugust 16, 2011
ConditionsThis study will analyze cellular and humoral immune responses after seasonal vaccination against influenza. Healthy adults are vaccinated with a licensed trivalent inactivated vaccine without adjuvant. The vaccine is licensed for all age groups studied in this study.MedDRA version: 14.0Level: LLTClassification code 10016794Term: Flu vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.0Level: LLTClassification code 10046859Term: VaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Immune system processes [G12]
DrugsPreflucel
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- This study will analyze cellular and humoral immune responses after seasonal vaccination against influenza. Healthy adults are vaccinated with a licensed trivalent inactivated vaccine without adjuvant. The vaccine is licensed for all age groups studied in this study.
- Sponsor
- Institute for Biomedical Aging Research
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •signed informed consent form
- •participant of the former MARK\-AGE study
- •no previous influenza vaccination in the 2011/2012 season
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 150
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 150
Exclusion Criteria
- •acute illness
- •chronic inflammatory disease (e.g. inflammatory bowl disease, Multiple Sclerosis)
- •chronic infection with HBV, HCV or HIV
- •transplant recipients
- •persons who have recieved chemotherapy in the past
- •persons under immunosuppressive therapy
- •pregnant women
- •participation in another clinical trial during the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Influenza Immunization in Adults Over Age 75InfluenzaImmunizationOlder AdultsOver Age 75NCT02200276Johns Hopkins University1,025
Not yet recruiting
Phase 4
Immune responses in health care personnel2024-515372-12-00Finnish Institute For Health And Welfare1,500
Active, not recruiting
Phase 4
Flu Vaccine Responses in the Setting of Melanoma TreatmentViral VaccinesNCT03315975University of Pennsylvania40
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-ESGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-CZGilead Sciences, Inc.22